Hennion & Walsh Asset Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.95M Sell
45,429
-550
-1% -$33.2K 0.11% 233
2026
Q1
$1.85M Sell
45,979
-10,967
-19% -$410K 0.06% 366
2025
Q4
$1.98M Buy
56,946
+605
+1% +$47.5K 0.07% 349
2025
Q3
$4.68M Buy
56,341
+7,850
+16% +$568K 0.17% 148
2025
Q2
$3.56M Buy
48,491
+2,342
+5% +$170K 0.14% 177
2025
Q1
$5.27M Sell
46,149
-1,973
-4% -$120K 0.23% 89
2024
Q4
$2.42M Sell
48,122
-21,205
-31% -$1.11M 0.11% 241
2024
Q3
$3.21M Buy
69,327
+9,838
+17% +$350K 0.15% 180
2024
Q2
$1.93M Buy
59,489
+4,620
+8% +$127K 0.1% 255
2024
Q1
$1.38M Buy
54,869
+15,335
+39% +$362K 0.07% 339
2023
Q4
$1.28M Sell
39,534
-573
-1% -$15.7K 0.07% 347
2023
Q3
$1.09M Buy
40,107
+6,756
+20% +$196K 0.07% 340
2023
Q2
$742K Buy
33,351
+3,406
+11% +$78.4K 0.04% 428
2023
Q1
$649K Buy
29,945
+9,851
+49% +$216K 0.04% 448
2022
Q4
$408K Buy
+20,094
New +$504K 0.03% 541
2021
Q2
Sell
-10,771
Closed -$256K 731
2021
Q1
$256K Buy
+10,771
New +$288K 0.02% 632

Other funds holding CORT